MedPath

Ohio State University Comprehensive Cancer Center

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.cancer.osu.edu

Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer

Phase 2
Completed
Conditions
Anxiety Disorder
Depression
Recurrent Breast Cancer
Stage IA Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IB Breast Cancer
Stage IIIC Breast Cancer
Interventions
Other: placebo
Other: laboratory biomarker analysis
Other: Questionnaire administration
First Posted Date
2014-07-30
Last Posted Date
2025-01-08
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
56
Registration Number
NCT02203552
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Light Sedation or Intubated General Anesthesia in Patients With Brain Cancer Undergoing Craniotomy

Phase 4
Completed
Conditions
Adult Brain Tumor
Interventions
Other: Arm II (intubated general anesthesia)
Other: Arm I (light sedation)
First Posted Date
2014-07-17
Last Posted Date
2019-03-13
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
4
Registration Number
NCT02193568
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients with Hormone Responsive Stage 0-I Breast Cancer

Not Applicable
Active, not recruiting
Conditions
Estrogen Receptor-positive Breast Cancer
Medullary Ductal Breast Carcinoma with Lymphocytic Infiltrate
Tubular Ductal Breast Carcinoma
Invasive Ductal Breast Carcinoma
Invasive Ductal Breast Carcinoma with Predominant Intraductal Component
Mucinous Ductal Breast Carcinoma
Papillary Ductal Breast Carcinoma
Progesterone Receptor-positive Breast Cancer
Stage IA Breast Cancer
Stage IB Breast Cancer
Interventions
Radiation: accelerated partial breast irradiation
Radiation: intensity-modulated radiation therapy
Radiation: image-guided radiation therapy
Procedure: therapeutic conventional surgery
First Posted Date
2014-07-10
Last Posted Date
2025-02-03
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
22
Registration Number
NCT02186470
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Phase 2
Completed
Conditions
Ductal Breast Carcinoma in Situ
Breast Cancer, Stage I
Breast Cancer, Stage II
Breast Cancer, Stage III
Interventions
Dietary Supplement: omega-3 fatty acid
Other: placebo
Behavioral: Questionnaire administration
First Posted Date
2014-05-30
Last Posted Date
2018-08-09
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
52
Registration Number
NCT02150525
Locations
🇺🇸

The Ohio State University Medical Center, Comprehensive Breast Center, Columbus, Ohio, United States

Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery

Not Applicable
Completed
Conditions
Stage I Prostate Cancer
Stage IIA Prostate Cancer
Stage IV Prostate Cancer
Stage III Prostate Cancer
Stage IIB Prostate Cancer
Interventions
Dietary Supplement: dietary intervention (tangerine tomato juice)
Dietary Supplement: dietary intervention (red tomato juice)
Other: questionnaire administration
Other: Correlative studies
First Posted Date
2014-05-22
Last Posted Date
2019-08-30
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
45
Registration Number
NCT02144649
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

🇺🇸

OhioHealth Dublin Methodist Hospital, Dublin, Ohio, United States

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

Completed
Conditions
Breast Cancer
First Posted Date
2014-04-29
Last Posted Date
2023-02-27
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
62
Registration Number
NCT02125019
Locations
🇺🇸

Ohio State University Wexner Medical Center, Columbus, Ohio, United States

Adherence to Colon Cancer Screening (ACCS)

Not Applicable
Completed
Conditions
Rectal Cancer
Colon Cancer
Interventions
Other: Patient Navigator
First Posted Date
2014-04-14
Last Posted Date
2021-03-10
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
1900
Registration Number
NCT02112747
Locations
🇺🇸

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio, United States

Community Awareness, Resources and Education (CARE I): Project 3

Completed
Conditions
Cervical Abnormality
First Posted Date
2014-04-14
Last Posted Date
2015-04-28
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
2394
Registration Number
NCT02113514
Locations
🇺🇸

The Ohio State University, Columbus, Ohio, United States

🇺🇸

University of Michigan, Ann Arbor, Michigan, United States

Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy

Not Applicable
Withdrawn
Conditions
Stage IIIB Non-small Cell Lung Cancer
Stage III Malignant Mesothelioma
Stage IV Non-small Cell Lung Cancer
Stage IV Malignant Mesothelioma
Interventions
Procedure: therapeutic conventional surgery
Drug: photodynamic therapy
First Posted Date
2014-04-08
Last Posted Date
2019-03-21
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Registration Number
NCT02106559

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Phase 2
Completed
Conditions
Recurrent Melanoma
Tumors Metastatic to Brain
Liver Metastases
Lung Metastases
Stage IV Melanoma
Interventions
Biological: ipilimumab
Radiation: stereotactic radiosurgery
Other: laboratory biomarker analysis
First Posted Date
2014-04-08
Last Posted Date
2024-05-21
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Target Recruit Count
8
Registration Number
NCT02107755
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath